Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity to Integrate IPA with Integromics' NGS Software


Ingenuity and Integromics said this week that they plan to integrate Integromics SeqSolve next-generation sequence analysis software with Ingenuity's IPA software.

Ingenuity has already integrated three other Integromics products with IPA: Integromics Biomarker Discovery for microarray data analysis, RealTime StatMiner used for the analysis of qPCR data, and OmicsHub Proteomics used for the analysis and storage of proteomics data.

Integromics released its first product for NGS data analysis last December. SeqSolve includes a broad RNA-seq analysis portfolio, including differential gene expression measurement among other features (BI 12/03/2011).

According to the partners, the combined tools will enable users to go from the aligned sequences to the function, interactions, pathways, and disease association of the genes or variant forms identified in the experiment.

Michael McManus, Integromics' CEO, said in a statement that his firm "can offer the market a spectrum of coverage spanning from microarrays to NGS data and proteomics" and by working with Ingenuity, it can provide "a consistent interface to IPA’s pathway data and biological context in each of the Integromics products.”

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.